GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lavipharm LAVI.AT · EUR

Health Care · Athens · 🇬🇷 Greece

Compare

1.49

+2.76%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€62.6m

FY2016FY2025

Net income

€6.0m

FY2016FY2025

Free cash flow

€2.1m

FY2016FY2025

Shareholders' equity

€56.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue€62.6m€52.9m€50.9m€39.1m€39.7m€37.6m€33.6m€31.8m€31.6m€32.0m
Gross profit€28.8m€23.7m€23.2m€16.4m€14.7m€15.1m€14.9m€14.7m€14.2m€14.6m
Research and development€344,000€285,000€195,000€365,000€812,000€753,000€290,000€410,000€299,000€249,000
Operating income€7.2m€4.3m€4.2m€2.7m−€398,000€2.0m€876,000−€370,000€1.2m−€2.6m
Net income€6.0m€9.0m€1.9m€834,000€1.7m€2.1m€5.3m€1.2m€12.9m€3.7m
Diluted earnings per share0.040.050.010.000.090.110.290.010.070.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets€130.7m€125.7m€114.8m€114.3m€53.0m€50.6m€49.9m€41.9m€44.9m€48.7m
Cash and short-term investments€6.1m€5.6m€8.4m€18.2m€1.6m€1.9m€1.7m€1.8m€2.3m€1.7m
Total liabilities€74.3m€72.7m€72.1m€74.0m€62.9m€62.9m€64.3m€61.4m€64.8m€105.6m
Debt€28.4m€33.8m€32.4m€37.1m€37.3m€36.3m€40.7m€40.5m€41.5m€79.1m
Shareholders' equity€56.4m€53.0m€42.7m€40.3m−€10.0m−€12.3m−€14.4m−€19.5m−€19.9m−€31.8m
Shares outstanding169m169m168m168m18m18m18m174m174m174m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations€6.7m€4.8m€539,000€3.4m€3.8m€2.9m€2.9m€1.4m€1.5m€622,000
Capital spending−€4.6m−€9.6m−€4.1m−€35.6m−€1.9m−€1.5m−€2.4m−€1.0m−€350,000−€97,000
Free cash flow€2.1m−€4.8m−€3.6m−€32.2m€1.9m€1.4m€483,000€398,000€1.2m€525,000
Dividends paid−€3.4m—————————

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
Revenue€34.4m€35.9m€26.7m€26.6m€26.3m€21.5m€29.5m€24.8m
Gross profit€14.6m€17.0m€12.4m€12.2m€11.5m€10.5m€11.7m€8.8m
Operating income€3.8m€4.5m€12.4m€2.1m€2.2m€426,000€3.6m€429,000
Net income€2.4m€3.4m€2.6m€1.2m€7.7m−€347,000€2.2m−€1.1m
Diluted earnings per share0.010.020.020.010.05-0.000.01-0.01
Cash from operations—€6.0m—€1.0m€3.0m−€1.0m€1.0m€1.0m
Capital spending−€12.0m−€3.0m−€1.0m−€6.0m−€3.0m−€2.0m−€1.0m−€35.0m
Free cash flow—€3.0m—−€5.0m€0−€3.0m€0−€34.0m
Total assets€140.1m€130.7m€126.9m€125.7m€123.6m€114.8m€117.9m€114.3m
Cash and short-term investments€3.6m€6.1m€6.2m€5.6m€8.7m€8.4m€16.4m€18.2m
Debt€9.7m€17.8m€5.1m€18.0m€15.4m€21.4m€24.6m€37.1m
Shareholders' equity€56.4m€56.4m€56.1m€53.0m€51.2m€42.7m€42.5m€40.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue17.0%10.7%9.0%
Operating income38.6%29.6%—
Net income92.9%23.4%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin45.5%44.8%43.1%44.5%
Operating margin9.9%8.9%7.0%3.9%
Net margin13.0%8.6%7.6%8.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings27.414.971.477.317.211.52.154.36.211.4
Price to sales2.62.52.61.60.80.60.32.12.51.3

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 17 Jul 2025.

FY2025FY2007FY2005FY2003FY2002FY2001FY2000FY1999
Paid in the year0.020.1680.1120.1120.1680.16454.0054.00
  • 3-to-1 reverse split · 1 Aug 2022
  • 2-for-1 split · 23 Jul 1999
  • 1.1-for-1 split · 17 Dec 1998
  • 6-for-5 split · 17 Mar 1997

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.